Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles

IntroductionOligometastatic ovarian cancer (OMOC) represents a distinct clinical state with a limited metastatic burden, potentially amenable to local ablative strategies. Stereotactic body radiotherapy (SBRT) has emerged as a promising treatment in this context, offering high-dose precision with mi...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mauro Francesco Pio Maiorano, Brigida Anna Maiorano
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-10-01
Sarja:	Frontiers in Pharmacology
Aiheet:	ovarian cancer oligometastatic ovarian cancer ovarian cancer radiotherapy advanced ovarian cancer survival stereotactic body radiotherapy ovarian cancer sbrt ovarian cancer, systematic review omoc
Linkit:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1620922/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!